Market definition is integral to a competition authority’s ability to sanction anti-competitive practices under Article 102 TFEU.  If the market is defined narrowly, a company is more likely to have a dominant position and thus is more likely to face increased scrutiny of its commercial strategies.  In the pharmaceutical sector, recent developments indicate that originators face a heightened risk that competition authorities will take a narrow approach when defining the relevant market. 
Continue Reading Market Definition in the Pharmaceutical Sector: Incentives in Article 102 Cases